Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Mona Mikhail

Psychiatry Bridgeville, PA Medical Doctor

NPI 1467416784 CMS profile 20504

1840 Mayview Rd, Ste 103, Suite 102, Bridgeville, PA 15017

Open in the dashboard

General payments

$7,339

502 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Mona Mikhail of Bridgeville, PA is reported in the CMS Open Payments database as having received $7,339 across 502 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $221 2
2021 General $1,729 99
2020 General $2,129 140
2019 General $3,259 261

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mona Mikhail
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Mona Mikhail were reported at $0. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Mona Mikhail Psychiatry median Middle half National median
2019 $3,259 $184 $59–$605 $163
2020 $2,129 $119 $36–$372 $114
2021 $1,729 $143 $43–$576 $132
2022 $0 $153 $50–$590 $149
2023 $0 $170 $56–$651 $160
2024 $221 $179 $57–$673 $164
2025 $0 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Lundbeck LLC $1,592 118 payments
  2. Otsuka America Pharmaceutical, Inc. $1,032 62 payments
  3. Sunovion Pharmaceuticals Inc. $830 64 payments
  4. Bausch Health US, LLC $712 58 payments
  5. Takeda Pharmaceuticals U.S.A., Inc. $645 40 payments
  6. Allergan Inc. $534 65 payments
  7. Janssen Pharmaceuticals, Inc $426 24 payments
  8. Jazz Pharmaceuticals Inc. $421 18 payments
  9. Vanda Pharmaceuticals Inc. $199 5 payments
  10. Teva Pharmaceuticals USA, Inc. $170 8 payments
  11. Other $777 40 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Food and Beverage $7,333 501 payments
  2. Education $6 1 payment
Products named General payments · program years 2019–2024
  1. REXULTI Psychiatry $1,193 90 payments
  2. REXULTI Psychiatry $1,032 62 payments
  3. LATUDA $830 64 payments
  4. APLENZIN $712 58 payments
  5. TRINTELLIX $555 35 payments
  6. VRAYLAR $534 65 payments
  7. WELLBUTRIN $440 43 payments
  8. BRINTELLIX $400 28 payments
  9. SPRAVATO $389 22 payments
  10. SUNOSI $368 15 payments
  11. Other $2,002 82 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

502 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record